Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Apple
AAPL
|
$168M |
| 2 |
Exxon Mobil
XOM
|
$120M |
| 3 |
GE HealthCare
GEHC
|
$103M |
| 4 |
Visa
V
|
$96.1M |
| 5 |
Meta Platforms (Facebook)
META
|
$92.1M |
Top Sells
| 1 |
Walmart
WMT
|
$331M |
| 2 |
JPMorgan Chase
JPM
|
$199M |
| 3 |
GE Aerospace
GE
|
$102M |
| 4 |
Thermo Fisher Scientific
TMO
|
$98.9M |
| 5 |
ConocoPhillips
COP
|
$80.4M |
Sector Composition
| 1 | Technology | 16.86% |
| 2 | Financials | 16.13% |
| 3 | Industrials | 13.08% |
| 4 | Healthcare | 11.06% |
| 5 | Consumer Discretionary | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3251
DURECT Corp
DRRX
$60.2M
| $150K | ﹤0.01% |
33,010
+9,434
| +40% | +$42.7K |
|
3252
Alpha Teknova
TKNO
$227M
| $148K | ﹤0.01% |
49,940
+39,086
| +360% | +$116K |
|
3253
Cosan
CSAN
$2.26B
| $148K | ﹤0.01% |
12,492
+64
| +0.5% | +$756 |
|
3254
Beasley Broadcasting Group
BBGI
$8.3M
| $147K | ﹤0.01% |
178,367
-33,221
| -16% | -$27.4K |
|
3255
Lifecore Biomedical
LFCR
$288M
| $147K | ﹤0.01% |
38,897
-1,718,647
| -98% | -$6.49M |
|
3256
Byrna Technologies
BYRN
$461M
| $145K | ﹤0.01% |
19,123
| – | – |
|
|
IMA
3257
ImageneBio, Inc. Common Stock
IMA
$153M
| $143K | ﹤0.01% |
41,439
+12,757
| +44% | +$44.2K |
|
|
VIOT
3258
Viomi Technology
VIOT
$224M
| $142K | ﹤0.01% |
138,202
-70,659
| -34% | -$72.6K |
|
3259
AvePoint
AVPT
$3.41B
| $142K | ﹤0.01% |
+34,424
| New | +$142K |
|
3260
Q32 Bio
QTTB
$20.9M
| $140K | ﹤0.01% |
135,740
-21,872
| -14% | -$22.5K |
|
3261
Microbot Medical
MBOT
$172M
| $138K | ﹤0.01% |
66,207
-26,248
| -28% | -$54.6K |
|
|
IMMP
3262
Immutep
IMMP
$237M
| $138K | ﹤0.01% |
81,928
+10,813
| +15% | +$18.2K |
|
3263
Nkarta
NKTX
$149M
| $138K | ﹤0.01% |
38,759
-29,935
| -44% | -$106K |
|
3264
Energy Services of America
ESOA
$162M
| $137K | ﹤0.01% |
59,999
+9,068
| +18% | +$20.8K |
|
3265
Century Therapeutics
IPSC
$40.4M
| $137K | ﹤0.01% |
39,453
-24,857
| -39% | -$86.3K |
|
3266
McEwen Inc.
MUX
$753M
| $135K | ﹤0.01% |
15,954
| – | – |
|
3267
Adverum Biotechnologies
ADVM
$68.2M
| $132K | ﹤0.01% |
184,146
-16,828
| -8% | -$12.1K |
|
|
CMCM
3268
Cheetah Mobile
CMCM
$184M
| $132K | ﹤0.01% |
50,717
-39,985
| -44% | -$104K |
|
|
SALM
3269
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
| $132K | ﹤0.01% |
120,746
-34,734
| -22% | -$37.9K |
|
3270
Gossamer Bio
GOSS
$587M
| $131K | ﹤0.01% |
+104,100
| New | +$131K |
|
3271
Eventbrite
EB
$262M
| $130K | ﹤0.01% |
15,200
| – | – |
|
|
VNTR
3272
DELISTED
Venator Materials PLC
VNTR
| $129K | ﹤0.01% |
318,431
-176,821
| -36% | -$71.5K |
|
3273
Ocular Therapeutix
OCUL
$2.25B
| $128K | ﹤0.01% |
24,319
-210,464
| -90% | -$1.11M |
|
3274
Barnwell Industries
BRN
$11.3M
| $127K | ﹤0.01% |
57,848
+4,144
| +8% | +$9.12K |
|
|
LENZ
3275
LENZ Therapeutics
LENZ
$1.12B
| $127K | ﹤0.01% |
51,758
+2,439
| +5% | +$5.97K |
|